Latest European Markets News

CSL Limited reported a solid 5% revenue increase and 6% rise in net profit after tax for the half year ended December 2024, underpinned by robust performance in its plasma therapies business despite headwinds in its influenza vaccine segment.

Domino's Pizza Enterprises signals a strategic reset with the closure of 205 underperforming stores, primarily in Japan, aiming to sharpen focus and improve profitability while maintaining steady earnings guidance.

Redivium Limited has successfully completed the formalities for listing a €25 million green bond, aimed at accelerating its sustainable battery recycling projects across Europe, including the UK, Czech Republic, and Romania.

Redivium Limited’s recent entitlement offer failed to meet the minimum subscription, leading to its cancellation and full refunds to investors. The company now pivots towards a green bond funding strategy to support its battery recycling ambitions.

Argent BioPharma reports strategic cost-cutting moves including facility closures and delisting from the LSE, while securing German distribution approval and raising significant capital to support its drug pipeline.

Harvest Technology Group reported a robust 32% revenue increase and secured strategic partnerships to drive its path to profitability by FY27. The company also raised over $3 million through convertible notes to support expansion efforts.

Surefire Resources NL advances its flagship Victory Bore project with a formal Expression of Interest from Germany’s HMS Bergbau, while new gold and copper targets emerge at the Yidby Project following recent drilling successes.

Manhattan Corporation has secured a pivotal Farm-In Agreement with Novo Resources for its Tibooburra Gold Project and gained surface access to progress drilling at its Chebogue Lithium Project in Canada, underpinning its exploration ambitions.

Adslot Ltd reports a robust Q2 FY25 with significant contract wins for its StoreFront platform and a 43% quarter-on-quarter increase in monetised transaction value, despite ongoing challenges in the Australian market.

Little Green Pharma reports a robust 75% revenue increase to $9.5 million for December quarter, driven by strong European market growth and strategic product launches.

Medical Developments International has posted a robust improvement in operating cash flow and revenue for Q2 FY25, driven by higher demand and pricing for its flagship product Penthrox across Australia and Europe.

Evion Group has initiated shipments from its expandable graphite joint venture in India, securing initial sales of A$2 million, while making significant progress on mining licenses and community support for its Maniry Graphite Project in Madagascar.